yahoo finance

AstraZeneca’s Heart Drug Gets FDA Nod For Stroke Reduction Use

AstraZeneca announced that the US regulator has approved its heart treatment Brilinta to be used to reduce the risk of an attack in …

Uber Posts Worse-Than-Feared Loss On Weak Rides Demand; Wedbush Raises PT

Uber Technologies posted a larger-than-expected loss in the third quarter, as the company’s core ride-hailing business continues to grapple with the Covid-19 impact, …

Walmart To Record $1B Loss From Argentina Business Sale

Walmart announced on Friday that it has agreed to sell its retail business in Argentina to Latin American group Grupo de Narváez, for …

Buffett’s Berkshire Operating Profit Sinks 32%, Buys Back $9B In Stock

Billionaire Warren Buffett’s Berkshire Hathaway posted a 32% decline in quarterly operating profit, while bumping up its share repurchases as the coronavirus pandemic …

Merck Snaps Up VelosBio In $2.75B Oncology Deal; Shares Rise

Merck & Co has entered into a definitive agreement to snap up all outstanding shares of VelosBio for $2.75 billion in cash, in …

AstraZeneca Expects Covid-19 Trial Data By Year-End, Backs 2020 Guidance

AstraZeneca will present late-stage trial data for its Covid-19 vaccine candidate later this year as the UK drugmaker said it is on track …

Apple To Face Chip Shortage For New iPhones – Report

Apple Inc. is struggling with a shortage of vital chips that manage power consumption in iPhones and other devices, raising concerns over its …

Hologic Quarterly Profit Triples On Covid-19 Test Sales; Shares Rise

Hologic saw its quarterly earnings more than triple bolstered by strong demand for its COVID-19 tests, sending shares up 2.4% in Thursday’s pre-market …

Manitowoc Posts Smaller Loss Than Feared, Reinstates Guidance; Shares Jump 8%

Shares of Manitowoc Co. jumped more than 8% in Wednesday’s late trading session after the producer of construction trains posted a smaller quarterly …

Biogen Rockets 44% On “Substantial Evidence” For Alzheimer’s Drug Approval

Shares of Biogen exploded 44% after staff at the US Food and Drug Administration (FDA) concluded in a review that there was “substantial …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts